Actively Recruiting
Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study
Led by Jin Joo Park · Updated on 2026-06-01
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the clinical usefulness of quantitative electrocardiography (QCG) by examining its connections with clinical features and lab results in patients hospitalized for acute heart failure. This observational study aims to gather important data to better understand how QCG relates to patient health and outcomes. Participants are adults aged 19 or older admitted for acute heart failure who have undergone at least one electrocardiogram. The study does not involve any treatment or intervention but focuses on collecting and analyzing clinical and laboratory data during hospitalization and follow-up. During the study, researchers will monitor participants for one year after enrollment, tracking outcomes such as mortality rates and changes in left ventricular ejection fraction (LVEF). The study involves reviewing electrocardiograms, laboratory tests, and clinical characteristics to evaluate the potential role of QCG in managing acute heart failure.
CONDITIONS
Brief Title
Acute Heart Failure Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
- NT-proBNP ≥300 pg/mL
- Patients who underwent electrocardiography at least once
You will not qualify if you...
- History of congenital heart disease
- Patients with a dominant electronic pacemaker rhythm
- Patients with a heart rate >140 beats per minute or electrocardiograms with excessive noise
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo electrocardiography and other assessments related to acute heart failure.
At least 1 electrocardiography assessment and periodic evaluations during follow-up
Duration - 1 year from enrollment
Participants are observed for clinical outcomes, including mortality and heart function changes over 1 year.
Periodic visits during the 1-year follow-up
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here